Company gears up for pivotal trials of AI-developed IPF drug candidate following encouraging Phase 2 data. AI-driven drug discovery powerhouse … Continue reading "Insilico seals unicorn status after landing $110m...
Immorta Bio is developing autologous stem cell and immunotherapy solutions to combat aging and enhance cellular regeneration. Aging is the … Continue reading "Harnessing the power of personalized cell therapy"...
London is the setting for the next edition of a premier global gathering for leaders in longevity research and technology … Continue reading "Founders Longevity Forum London reveals first wave...
Progress in spinal cord injury lays the foundation for regenerative therapies that ‘target aging and chronic disease at a cellular … Continue reading "Cellinoâs regenerative medicine tie-up with Matricelf is...
